Ginkgo Bioworks, Boehringer Enter Into Drug Discovery Partnership
Earlier Zymergen Acquisition Boosts Service Capacity
Deal Snapshot: Ginkgo will earn up to $406m in fees plus royalties as it works with Boehringer Ingelheim to mine its metagenomics database for drug candidates.
